{"title":"麝香保心丸通过PI3K/Akt/eNOS信号通路保护心肌细胞免受MIRI多靶点的影响","authors":"na wei, zhen bin liu, si yuan li, yuan Gao","doi":"10.1101/2023.11.13.566957","DOIUrl":null,"url":null,"abstract":"Background: Myocardial ischemia-reperfusion injury (MIRI) can significantly aggravate myocardial injury in patients with ST-segment elevation myocardial infarction (STEMI). At present, there are few effective treatments for MIRI. The Shexiang Baoxin Pill (SBP) can reduce MIRI. The PI3K/Akt/eNOS signaling pathway, inflammation, oxidative stress, and apoptosis are all involved in the regulation of MIRI. SBP has multi-component, multi-target, and synergistic effects, but its mechanism of action on MIRI has not been reported. Purpose: We sought to explore whether SBP exerts a protective mechanism by inhibiting the inflammatory reaction, oxidative stress, and apoptosis, reducing MIRI through the PI3K/Akt/eNOS signal pathway. Materials and methods: Hypoxia-reoxygenation (H/R) H9c2 cardiomyocytes were used as an in vitro model of MIRI. The active components of Shexiang Baoxin pills were extracted with water. The levels of phosphorylated proteins and genes related to the PI3K/Akt/eNOS pathway were measured by Western blotting and real-time fluorescence quantitative PCR. Cell viability, apoptosis rates, and apoptosis-related proteins (Bcl-2, Bax, Caspase-3) were detected by CCK-8, flow cytometry, and Western blotting. The expression of reactive oxygen species (ROS), homocysteine (Hcy), malondialdehyde (MDA), and gp91phox was detected by fluorescence probe, ELISA, TBA, and Western blotting. The levels of inflammatory factors (TNF-α, IL-6, IL-18) were measured by an ELISA method. Results: SBP increased the cell survival rate of H/R cardiomyocytes, reduced the injury to H/R cardiomyocytes, and increased the protein phosphorylation levels of p-PI3KY607, p-AktSer473, p-eNOSSer1177, and mRNA of H/R cardiomyocytes. In addition, SBP increased the level of Bcl-2 protein and the Bcl-2/Bax ratio and decreased the apoptosis rate and Bax and Caspase-3 expression. It reduced the levels of oxidative stress indexes (ROS, HCY, MDA, and gp91phox) and inflammatory factors (TNF-γ, IL-6, IL-18) and enhanced antioxidant stress, anti-apoptosis, and an anti-inflammatory reaction. The above effects were attenuated after the inhibition of the PI3K/Akt/eNOS signal pathway. Conclusion: We established that SBP extract inhibited oxidative stress, inflammatory response, and apoptosis through the PI3K/Akt/eNOS signal pathway and alleviated the injury of H9c2 cells induced by hypoxia-reoxygenation.","PeriodicalId":486943,"journal":{"name":"bioRxiv (Cold Spring Harbor Laboratory)","volume":"24 4","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Shexiang Baoxin Pill Protects Myocardial Cells from Multiple Targets of MIRI through the PI3K/Akt/eNOS Signal Pathway\",\"authors\":\"na wei, zhen bin liu, si yuan li, yuan Gao\",\"doi\":\"10.1101/2023.11.13.566957\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Myocardial ischemia-reperfusion injury (MIRI) can significantly aggravate myocardial injury in patients with ST-segment elevation myocardial infarction (STEMI). At present, there are few effective treatments for MIRI. The Shexiang Baoxin Pill (SBP) can reduce MIRI. The PI3K/Akt/eNOS signaling pathway, inflammation, oxidative stress, and apoptosis are all involved in the regulation of MIRI. SBP has multi-component, multi-target, and synergistic effects, but its mechanism of action on MIRI has not been reported. Purpose: We sought to explore whether SBP exerts a protective mechanism by inhibiting the inflammatory reaction, oxidative stress, and apoptosis, reducing MIRI through the PI3K/Akt/eNOS signal pathway. Materials and methods: Hypoxia-reoxygenation (H/R) H9c2 cardiomyocytes were used as an in vitro model of MIRI. The active components of Shexiang Baoxin pills were extracted with water. The levels of phosphorylated proteins and genes related to the PI3K/Akt/eNOS pathway were measured by Western blotting and real-time fluorescence quantitative PCR. Cell viability, apoptosis rates, and apoptosis-related proteins (Bcl-2, Bax, Caspase-3) were detected by CCK-8, flow cytometry, and Western blotting. The expression of reactive oxygen species (ROS), homocysteine (Hcy), malondialdehyde (MDA), and gp91phox was detected by fluorescence probe, ELISA, TBA, and Western blotting. The levels of inflammatory factors (TNF-α, IL-6, IL-18) were measured by an ELISA method. Results: SBP increased the cell survival rate of H/R cardiomyocytes, reduced the injury to H/R cardiomyocytes, and increased the protein phosphorylation levels of p-PI3KY607, p-AktSer473, p-eNOSSer1177, and mRNA of H/R cardiomyocytes. In addition, SBP increased the level of Bcl-2 protein and the Bcl-2/Bax ratio and decreased the apoptosis rate and Bax and Caspase-3 expression. It reduced the levels of oxidative stress indexes (ROS, HCY, MDA, and gp91phox) and inflammatory factors (TNF-γ, IL-6, IL-18) and enhanced antioxidant stress, anti-apoptosis, and an anti-inflammatory reaction. The above effects were attenuated after the inhibition of the PI3K/Akt/eNOS signal pathway. Conclusion: We established that SBP extract inhibited oxidative stress, inflammatory response, and apoptosis through the PI3K/Akt/eNOS signal pathway and alleviated the injury of H9c2 cells induced by hypoxia-reoxygenation.\",\"PeriodicalId\":486943,\"journal\":{\"name\":\"bioRxiv (Cold Spring Harbor Laboratory)\",\"volume\":\"24 4\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"bioRxiv (Cold Spring Harbor Laboratory)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2023.11.13.566957\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"bioRxiv (Cold Spring Harbor Laboratory)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2023.11.13.566957","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Shexiang Baoxin Pill Protects Myocardial Cells from Multiple Targets of MIRI through the PI3K/Akt/eNOS Signal Pathway
Background: Myocardial ischemia-reperfusion injury (MIRI) can significantly aggravate myocardial injury in patients with ST-segment elevation myocardial infarction (STEMI). At present, there are few effective treatments for MIRI. The Shexiang Baoxin Pill (SBP) can reduce MIRI. The PI3K/Akt/eNOS signaling pathway, inflammation, oxidative stress, and apoptosis are all involved in the regulation of MIRI. SBP has multi-component, multi-target, and synergistic effects, but its mechanism of action on MIRI has not been reported. Purpose: We sought to explore whether SBP exerts a protective mechanism by inhibiting the inflammatory reaction, oxidative stress, and apoptosis, reducing MIRI through the PI3K/Akt/eNOS signal pathway. Materials and methods: Hypoxia-reoxygenation (H/R) H9c2 cardiomyocytes were used as an in vitro model of MIRI. The active components of Shexiang Baoxin pills were extracted with water. The levels of phosphorylated proteins and genes related to the PI3K/Akt/eNOS pathway were measured by Western blotting and real-time fluorescence quantitative PCR. Cell viability, apoptosis rates, and apoptosis-related proteins (Bcl-2, Bax, Caspase-3) were detected by CCK-8, flow cytometry, and Western blotting. The expression of reactive oxygen species (ROS), homocysteine (Hcy), malondialdehyde (MDA), and gp91phox was detected by fluorescence probe, ELISA, TBA, and Western blotting. The levels of inflammatory factors (TNF-α, IL-6, IL-18) were measured by an ELISA method. Results: SBP increased the cell survival rate of H/R cardiomyocytes, reduced the injury to H/R cardiomyocytes, and increased the protein phosphorylation levels of p-PI3KY607, p-AktSer473, p-eNOSSer1177, and mRNA of H/R cardiomyocytes. In addition, SBP increased the level of Bcl-2 protein and the Bcl-2/Bax ratio and decreased the apoptosis rate and Bax and Caspase-3 expression. It reduced the levels of oxidative stress indexes (ROS, HCY, MDA, and gp91phox) and inflammatory factors (TNF-γ, IL-6, IL-18) and enhanced antioxidant stress, anti-apoptosis, and an anti-inflammatory reaction. The above effects were attenuated after the inhibition of the PI3K/Akt/eNOS signal pathway. Conclusion: We established that SBP extract inhibited oxidative stress, inflammatory response, and apoptosis through the PI3K/Akt/eNOS signal pathway and alleviated the injury of H9c2 cells induced by hypoxia-reoxygenation.